EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model

Thamara Gonçalves Reis, Alice Marcela Sampaio Del Colletto, Luiz Augusto Santana Silva, Bruna Andrade Aguiar Koga, Mari Cleide Sogayar iD, Ana Claudia Oliveira Carreira iD

Biomolecules · 2024

DOI: 10.3390/biom14030317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Thamara Gonçalves Reis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Molecular Therapy Group (NUCEL), School of Medicine, University of São Paulo, São Paulo 01246-903, SP, Brazil. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 7, Osteoporosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Brazilian National Council for Development and Technoly, Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone morphogenetic protein (BMP) and platelet-derived growth factor (PDGF) are known to regulate/stimulate osteogenesis, playing vital roles in bone homeostasis, rendering them strong candidates for osteoporosis treatment. We evaluated the effects of recombinant human BMP-7 (rhBMP7) and PDGF-BB (rhPDGF-BB) in an oophorectomy-induced osteoporosis rat model. Forty Sprague Dawley rats underwent oophorectomy surgery; treatments commenced on the 100th day post-surgery when all animals exhibited signs of osteoporosis. These peptide growth factors were administered intraocularly (iv) once or twice a week and the animals were monitored for a total of five weeks. Two weeks after the conclusion of the treatments, the animals were euthanized and tissues were collected for assessment of alkaline phosphatase, X-ray, micro-CT, and histology. The results indicate that the most promising treatments were 20 µg/kg rhPDGF-BB + 30 µg/kg rhBMP-7 twice a week and 30 µg/kg BMP-7 twice a week, showing significant increases of 15% (p < 0.05) and 13% (p < 0.05) in bone volume fraction and 21% (p < 0.05) and 23% (p < 0.05) in trabecular number, respectively. In conclusion, rhPDGF-BB and rhBMP-7 have demonstrated the ability to increase bone volume and density in this osteoporotic animal model, establishing them as potential candidates for osteoporosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 7OsteoporosisHumansRatsAnimalsBecaplerminProto-Oncogene Proteins c-sisRats, Sprague-DawleyRecombinant ProteinsBone Morphogenetic ProteinsBone Morphogenetic Protein 2

Stichwörter der Autor:innen

bone repairosteoporosisrecombinant peptide growth factorsrhBMP-7rhPDGF-BB

Substanzen

BecaplerminProto-Oncogene Proteins c-sisBone Morphogenetic Protein 7Recombinant ProteinsBone Morphogenetic ProteinsBone Morphogenetic Protein 2

Autor:innen und Institutionen

  • Cell and Molecular Therapy Group (NUCEL), School of Medicine, University of São Paulo, São Paulo 01246-903, SP, Brazil.
  • Biotechnology Graduate Program (PPG-USP), University of São Paulo, São Paulo 05508-900, SP, Brazil.
  • Surgery Department, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo 05508-270, SP, Brazil.
  • PathoDxVet, São Paulo 02925-000, SP, Brazil.
  • Biochemistry Department, Chemistry Institute, University of São Paulo, São Paulo 05588-000, SP, Brazil.

ORCID-Profile: Mari Cleide Sogayar, Ana Claudia Oliveira Carreira

Förderung

  • São Paulo Research Foundation
  • Brazilian National Council for Development and Technoly
  • Coordination for the Improvement of Higher Education Personnel
  • INCT-Regenera-CNPq
  • National Council for Scientific and Technological Development (CNPq)
  • Foundation for Research Support of São Paulo State (FAPESP)
  • Coordination for Improvement of Higher Education Personnel (CAPES)
  • National Institute of Science and Technology in Regenerative Medicine (INCT-Regenera)

Zitieren

APA

Reis, T. G., Del Colletto, A. M. S., Silva, L. A. S., Koga, B. A. A., Sogayar, M. C., & Carreira, A. C. O. (2024). Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model. Biomolecules. https://doi.org/10.3390/biom14030317

Vancouver

Reis TG, Del Colletto AMS, Silva LAS, Koga BAA, Sogayar MC, Carreira ACO. Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model. Biomolecules. 2024. doi:10.3390/biom14030317

BibTeX
@article{Reis2024,
  author = {Reis, Thamara Gonçalves and Del Colletto, Alice Marcela Sampaio and Silva, Luiz Augusto Santana and Koga, Bruna Andrade Aguiar and Sogayar, Mari Cleide and Carreira, Ana Claudia Oliveira},
  title = {Recombinant Human Peptide Growth Factors, Bone Morphogenetic Protein-7 (rhBMP7), and Platelet-Derived Growth Factor-BB (rhPDGF-BB) for Osteoporosis Treatment in an Oophorectomized Rat Model},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14030317}
}
Kostenlos starten →